JP2017513849A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513849A5
JP2017513849A5 JP2016562764A JP2016562764A JP2017513849A5 JP 2017513849 A5 JP2017513849 A5 JP 2017513849A5 JP 2016562764 A JP2016562764 A JP 2016562764A JP 2016562764 A JP2016562764 A JP 2016562764A JP 2017513849 A5 JP2017513849 A5 JP 2017513849A5
Authority
JP
Japan
Prior art keywords
composition
seq
fragment
variant
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016562764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017513849A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/050174 external-priority patent/WO2015157820A1/en
Publication of JP2017513849A publication Critical patent/JP2017513849A/ja
Publication of JP2017513849A5 publication Critical patent/JP2017513849A5/ja
Pending legal-status Critical Current

Links

JP2016562764A 2014-04-15 2015-04-15 A群レンサ球菌ワクチン Pending JP2017513849A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2014901382A AU2014901382A0 (en) 2014-04-15 Group a streptococcal vaccine
AU2014901382 2014-04-15
AU2014903042 2014-08-06
AU2014903042A AU2014903042A0 (en) 2014-08-06 Group a streptococcal vaccine
AU2014904453A AU2014904453A0 (en) 2014-11-05 Group a streptococcal vaccine
AU2014904453 2014-11-05
PCT/AU2015/050174 WO2015157820A1 (en) 2014-04-15 2015-04-15 Group a streptococcus vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020201171A Division JP7072921B2 (ja) 2014-04-15 2020-12-03 A群レンサ球菌ワクチン

Publications (2)

Publication Number Publication Date
JP2017513849A JP2017513849A (ja) 2017-06-01
JP2017513849A5 true JP2017513849A5 (enExample) 2018-04-26

Family

ID=54323282

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016562764A Pending JP2017513849A (ja) 2014-04-15 2015-04-15 A群レンサ球菌ワクチン
JP2020201171A Active JP7072921B2 (ja) 2014-04-15 2020-12-03 A群レンサ球菌ワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020201171A Active JP7072921B2 (ja) 2014-04-15 2020-12-03 A群レンサ球菌ワクチン

Country Status (16)

Country Link
US (2) US10301362B2 (enExample)
EP (1) EP3131575B1 (enExample)
JP (2) JP2017513849A (enExample)
KR (2) KR102730367B1 (enExample)
CN (1) CN106794236B (enExample)
AU (1) AU2015246654B2 (enExample)
BR (1) BR112016023915B1 (enExample)
CA (1) CA2945052C (enExample)
DK (1) DK3131575T3 (enExample)
IL (1) IL248266B (enExample)
MX (1) MX392514B (enExample)
MY (1) MY191217A (enExample)
NZ (1) NZ725212A (enExample)
SG (1) SG11201608380PA (enExample)
WO (1) WO2015157820A1 (enExample)
ZA (1) ZA201607355B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY191217A (en) 2014-04-15 2022-06-09 Univ Griffith Group a streptococcus vaccine
CN106606775A (zh) * 2015-10-27 2017-05-03 格里菲斯大学 脂质体a群链球菌疫苗
TWI598360B (zh) * 2016-12-19 2017-09-11 義守大學 Fsbm重組蛋白及其用途
CN111344007A (zh) * 2017-08-23 2020-06-26 格里菲斯大学 抗a组链球菌的免疫原性肽
CN110776508B (zh) * 2018-07-27 2021-07-16 海创药业股份有限公司 一种brd4抑制剂及其制备方法和用途
KR102437436B1 (ko) * 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
NL2023863B1 (en) 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5811105A (en) 1987-12-23 1998-09-22 Glaxo Wellcome, Inc. Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
GB9007194D0 (en) 1990-03-30 1990-05-30 Wellcome Found Live vaccines
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
AUPO007396A0 (en) 1996-05-24 1996-06-20 Csl Limited Ebv ctl epitopes
AUPO784197A0 (en) 1997-07-10 1997-08-07 Csl Limited Treatment of nasopharyngeal carcinoma
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
EP1879613B1 (en) * 2005-05-05 2011-11-30 Merck Sharp & Dohme Corp. Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
EP1962961B1 (en) 2005-11-29 2013-01-09 The University Of Sydney Demibodies: dimerisation-activated therapeutic agents
AU2007271350B2 (en) * 2006-07-07 2013-03-21 Intercell Ag Small Streptococcus pyogenes antigens and their use
US20090010929A1 (en) 2006-12-04 2009-01-08 Good Michael F Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates
US8482298B2 (en) 2006-12-18 2013-07-09 Schrader Electronics Ltd. Liquid level and composition sensing systems and methods using EMF wave propagation
CA2699513C (en) * 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
US20090162369A1 (en) * 2007-12-12 2009-06-25 Katin Helena Threse Nordstrom Synthetic chimeric peptides
JP5680536B2 (ja) 2008-09-17 2015-03-04 ノバルティス アーゲー 組み合わせgasワクチンおよび治療法
MY191217A (en) 2014-04-15 2022-06-09 Univ Griffith Group a streptococcus vaccine
CN111344007A (zh) * 2017-08-23 2020-06-26 格里菲斯大学 抗a组链球菌的免疫原性肽

Similar Documents

Publication Publication Date Title
JP2017513849A5 (enExample)
Turner et al. Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi
JP2015501656A5 (enExample)
JP2013520487A5 (enExample)
JP7072921B2 (ja) A群レンサ球菌ワクチン
JP2018509935A5 (enExample)
JP2010516290A5 (enExample)
EP3279217B1 (en) Streptococcus pneumoniae protein antigen, and preparation method and use thereof
JP2013523718A5 (enExample)
HRP20161305T1 (hr) Liječenje mikrobnih infekcija
JP2015514132A5 (enExample)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2017511133A5 (enExample)
JP2018537089A5 (enExample)
JP5661744B2 (ja) 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用
JP2020509770A5 (enExample)
JP2015513314A5 (enExample)
Zhang et al. The tissue factor pathway inhibitor 1 of Sciaenops ocellatus possesses antimicrobial activity and is involved in the immune response against bacterial infection
CN116262781B (zh) 抗菌肽defensin衍生物及其原核表达方法与应用
JP2020127419A5 (enExample)
Banks et al. Streptococcus sanguis secretes CD14-binding proteins that stimulate cytokine synthesis: a clue to the pathogenesis of infective (bacterial) endocarditis?
CN101684159B (zh) 人颗粒酶b蛋白衍生物及其在靶向治疗腺癌中的用途
Shuai et al. Purification and expression of a novel bacteriocin, JUQZ-1, against Pseudomonas syringae pv. Actinidiae (PSA), secreted by Brevibacillus laterosporus Wq-1, isolated from the rhizosphere soil of healthy kiwifruit
JP2009507474A5 (enExample)
CN107670023B (zh) V12cbd蛋白及其编码基因的一种新用途